Session Details

[S16]Structural Pharmaceutical Science: Structural Manipulation of Molecules for Drug Discovery

Sun. Mar 26, 2023 1:50 PM - 3:50 PM JST
Sun. Mar 26, 2023 4:50 AM - 6:50 AM UTC
[Room M2] The Alumni Hall "Frate": Seminar Room 1F
Organizer: Takashi Misawa, Shusuke Tomoshige
In these years, various modalities in drug discovery, including antibody drugs, PROTACs, and medium-sized drugs based on nucleic acids and peptides, have been emerging for drugging undruggable targets which are hard to drug in traditional drug discovery program (Angew. Chem. Int. Ed. 2017, 56, 10294; ACS Med. Chem. Lett. 2020, 11, 228). Recently, chemical manipulation of the conformation of the molecules such as small molecules, nucleic acid, and proteins, by means of conformational fixation and induction of conformational changes has been attracting medicinal chemists and has been opening up a new approach toward a novel modality in drug discovery.
In this symposium entitled "Structural Pharmaceutical Science: Structural Manipulation of Molecules for Drug Discovery," five researchers with a passion for working on structural manipulation of molecules using different methodologies will be giving talks on their own state-of-the-art technology. The symposiasts come from variety research fields not only pharmaceutical science but also other fields, and the symposium is hoped to intensify the activities of the heterogeneous community of structural pharmaceutical science.

趣旨説明:三澤 隆史(国立衛研)

[S16-01]Development of orexin receptor agonists based on three-dimensional conformation control

○Tsuyoshi Saitoh1 (1. IIIS, Univ. Tsukuba)

[S16-02]RNA Hacking with Staple Oligomers Rises to Nucleic Acid Medicines

○Yousuke Katsuda1 (1. Faculty of Advanced Science and Technology, Kumamoto University)

[S16-03]Chemical control of protein conformation stability towards the treatment for neurodegenerative disorders

○Shusuke Tomoshige1 (1. Grad. Sch. Life Sci., Tohoku Univ.)

[S16-04]Creation of carrier peptides containing α-aminoisobutyric acid for enhancement of efficiency in intracellular delivery

○Kayo Terada1 (1. Grad. Sch. Eng., Kyoto Univ.)

[S16-05]In silico analyses of essential interactions of iminosugars with HexA active site and evaluation of their pharmacological chaperone effect for Tay-Sachs disease

○Atsushi kato1 (1. Department of Hospital Pharmacy, University of Toyama)

総括:友重 秀介(東北大院生命)